These authors contributed equally to this work.
Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma
Version of Record online: 22 AUG 2013
© 2013 Japanese Cancer Association
Volume 104, Issue 11, pages 1411–1419, November 2013
How to Cite
(Cancer Sci 2013; 104: 1411–1419)
- Issue online: 30 OCT 2013
- Version of Record online: 22 AUG 2013
- Accepted manuscript online: 25 JUL 2013 02:55AM EST
- Manuscript Accepted: 21 JUL 2013
- Manuscript Revised: 9 JUL 2013
- Manuscript Received: 15 JAN 2013
|cas12240-sup-0001-FigS1.TIF||image/tif||94K||Fig. S1. Expression levels of miR-1291 in 20 human cancer cell lines.|
|cas12240-sup-0002-FigS2.TIF||image/tif||129K||Fig. S2. Cell cycle assays in miR-1291-transfected renal cell carcinoma cell lines.|
|cas12240-sup-0003-FigS3.TIF||image/tif||106K||Fig. S3. Strategy for selection of miR-1291 target genes.|
Table S1. Significantly enriched annotations regulated by miR-1291 in the TargetScan database.
Table S2. Candidate target genes of miR-1291 involved in ‘pathways in cancer’.
Table S3. Seventy-four differently expressed genes involved in the ‘pathway in cancer’.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.